BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 28460635)

  • 1. Transcriptomic profiling and quantitative high-throughput (qHTS) drug screening of CDH1 deficient hereditary diffuse gastric cancer (HDGC) cells identify treatment leads for familial gastric cancer.
    Chen I; Mathews-Greiner L; Li D; Abisoye-Ogunniyan A; Ray S; Bian Y; Shukla V; Zhang X; Guha R; Thomas C; Gryder B; Zacharia A; Beane JD; Ravichandran S; Ferrer M; Rudloff U
    J Transl Med; 2017 May; 15(1):92. PubMed ID: 28460635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Merging perspectives: genotype-directed molecular therapy for hereditary diffuse gastric cancer (HDGC) and E-cadherin-EGFR crosstalk.
    Li D; Lo W; Rudloff U
    Clin Transl Med; 2018 Feb; 7(1):7. PubMed ID: 29468433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.
    van der Post RS; Vogelaar IP; Manders P; van der Kolk LE; Cats A; van Hest LP; Sijmons R; Aalfs CM; Ausems MG; Gómez García EB; Wagner A; Hes FJ; Arts N; Mensenkamp AR; van Krieken JH; Hoogerbrugge N; Ligtenberg MJ
    Gastroenterology; 2015 Oct; 149(4):897-906.e19. PubMed ID: 26072394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cleft lip/palate and hereditary diffuse gastric cancer: report of a family harboring a CDH1 c.687 + 1G > A germline mutation and review of the literature.
    Obermair F; Rammer M; Burghofer J; Malli T; Schossig A; Wimmer K; Kranewitter W; Mayrbaeurl B; Duba HC; Webersinke G
    Fam Cancer; 2019 Apr; 18(2):253-260. PubMed ID: 30306390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hereditary Diffuse Gastric Cancer Syndrome: CDH1 Mutations and Beyond.
    Hansford S; Kaurah P; Li-Chang H; Woo M; Senz J; Pinheiro H; Schrader KA; Schaeffer DF; Shumansky K; Zogopoulos G; Santos TA; Claro I; Carvalho J; Nielsen C; Padilla S; Lum A; Talhouk A; Baker-Lange K; Richardson S; Lewis I; Lindor NM; Pennell E; MacMillan A; Fernandez B; Keller G; Lynch H; Shah SP; Guilford P; Gallinger S; Corso G; Roviello F; Caldas C; Oliveira C; Pharoah PD; Huntsman DG
    JAMA Oncol; 2015 Apr; 1(1):23-32. PubMed ID: 26182300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations of CDH1 germline variant location and cancer phenotype in families with hereditary diffuse gastric cancer (HDGC).
    Lo W; Zhu B; Sabesan A; Wu HH; Powers A; Sorber RA; Ravichandran S; Chen I; McDuffie LA; Quadri HS; Beane JD; Calzone K; Miettinen MM; Hewitt SM; Koh C; Heller T; Wacholder S; Rudloff U
    J Med Genet; 2019 Jun; 56(6):370-379. PubMed ID: 30745422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of epigenetic and genetic 2nd hits in CDH1 during hereditary diffuse gastric cancer syndrome progression.
    Oliveira C; Sousa S; Pinheiro H; Karam R; Bordeira-Carriço R; Senz J; Kaurah P; Carvalho J; Pereira R; Gusmão L; Wen X; Cipriano MA; Yokota J; Carneiro F; Huntsman D; Seruca R
    Gastroenterology; 2009 Jun; 136(7):2137-48. PubMed ID: 19269290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening E-cadherin in gastric cancer families reveals germline mutations only in hereditary diffuse gastric cancer kindred.
    Oliveira C; Bordin MC; Grehan N; Huntsman D; Suriano G; Machado JC; Kiviluoto T; Aaltonen L; Jackson CE; Seruca R; Caldas C
    Hum Mutat; 2002 May; 19(5):510-7. PubMed ID: 11968083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of c.1531C>T Pathogenic Variant in the
    Norero E; Alarcon MA; Hakkaart C; de Mayo T; Mellado C; Garrido M; Aguayo G; Lagos M; Torres J; Calvo A; Guilford P; Corvalan AH
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31600923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastric cancer: new genetic developments.
    Lynch HT; Grady W; Suriano G; Huntsman D
    J Surg Oncol; 2005 Jun; 90(3):114-33; discussion 133. PubMed ID: 15895459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDH1 gene mutations do not contribute in hereditary diffuse gastric cancer in Poland.
    Jakubowska A; Lawniczak M; Wojnarska B; Cybulski C; Huzarski T; Byrski T; Tołoczko-Grabarek A; Jaworska K; Durda K; Starzyńska T; Lubiński J
    Fam Cancer; 2010 Dec; 9(4):605-8. PubMed ID: 20842455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germline likely pathogenic variants in ataxia-telangiectasia-mutated gene in an Iranian family with hereditary diffuse gastric cancer without
    Kheirollahi M; Saneipour M; Moridnia A
    J Cancer Res Ther; 2021; 17(6):1434-1437. PubMed ID: 34916374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CDH1 and hereditary diffuse gastric cancer: a narrative review.
    Gregory SN; Davis JL
    Chin Clin Oncol; 2023 Jun; 12(3):25. PubMed ID: 37303221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E-Cadherin (CDH1) and p53 rather than SMAD4 and Caspase-10 germline mutations contribute to genetic predisposition in Portuguese gastric cancer patients.
    Oliveira C; Ferreira P; Nabais S; Campos L; Ferreira A; Cirnes L; Alves CC; Veiga I; Fragoso M; Regateiro F; Dias LM; Moreira H; Suriano G; Machado JC; Lopes C; Castedo S; Carneiro F; Seruca R
    Eur J Cancer; 2004 Aug; 40(12):1897-903. PubMed ID: 15288293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E-cadherin alterations in hereditary disorders with emphasis on hereditary diffuse gastric cancer.
    Oliveira C; Pinheiro H; Figueiredo J; Seruca R; Carneiro F
    Prog Mol Biol Transl Sci; 2013; 116():337-59. PubMed ID: 23481202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the E-cadherin gene (CDH1) in diffuse gastric cancer susceptibility: from the laboratory to clinical practice.
    Graziano F; Humar B; Guilford P
    Ann Oncol; 2003 Dec; 14(12):1705-13. PubMed ID: 14630673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CDH1 germline mutations in a Chinese cohort with hereditary diffuse gastric cancer.
    Pan Z; Fu Z; Luo C; Bao Y; Wang M; Cao W; Xu X
    J Cancer Res Clin Oncol; 2022 Aug; 148(8):2145-2151. PubMed ID: 34537906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria.
    Brooks-Wilson AR; Kaurah P; Suriano G; Leach S; Senz J; Grehan N; Butterfield YS; Jeyes J; Schinas J; Bacani J; Kelsey M; Ferreira P; MacGillivray B; MacLeod P; Micek M; Ford J; Foulkes W; Australie K; Greenberg C; LaPointe M; Gilpin C; Nikkel S; Gilchrist D; Hughes R; Jackson CE; Monaghan KG; Oliveira MJ; Seruca R; Gallinger S; Caldas C; Huntsman D
    J Med Genet; 2004 Jul; 41(7):508-17. PubMed ID: 15235021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CDH1 associated gastric cancer: a report of a family and review of the literature.
    Moran CJ; Joyce M; McAnena OJ
    Eur J Surg Oncol; 2005 Apr; 31(3):259-64. PubMed ID: 15780560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic and prophylactic gastrectomy in a family with hereditary diffuse gastric cancer secondary to a CDH1 mutation: a case series.
    Gjyshi O; Vashi P; Seewald L; Kohan M; Abboud E; Fowler E; Suppiah R; Halabi H
    World J Surg Oncol; 2018 Jul; 16(1):143. PubMed ID: 30007404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.